XML 19 R7.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Statements of Cash Flows
$ in Thousands
 3 Months Ended
Mar. 31, 2024
USD ($)
Mar. 31, 2023
USD ($)
Cash flows from operating activities:    
Net loss $ (120,656) $ (23,447)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 414 296
Bad debt expense 1,660 0
Share-based compensation expense 3,926 207
Change in fair value of SAFE Agreements 0 2,353
Change in fair value of earn-out liabilities 22,597 3,726
Change in fair value of warrant liabilities 23,964 0
Loss on issuance of securities 68,676 0
Other 0 582
Changes in operating assets and liabilities:    
Trade accounts receivable, net (20,002) (1,006)
Contract assets (13,357) (4,727)
Prepaid expenses 305 (2,785)
Other assets, net 429 178
Accounts payable and accrued expenses 30,658 6,994
Accounts payable – affiliated companies 4,411 170
Contract liabilities – current and long-term (13,172) (8,140)
Other liabilities 3,705 6,933
Net cash used in operating activities (6,442) (18,666)
Cash flows from investing activities:    
Purchase of property and equipment (1,588) (8,565)
Net cash used in investing activities (1,588) (8,565)
Cash flows from financing activities:    
Proceeds from Business Combination 0 8,055
Proceeds from issuance of Series A Preferred Stock 0 26,000
Transaction costs 0 (782)
Proceeds from borrowings 10,000 0
Repayment of loans (10,000) 0
Proceeds from issuance of securities 10,000 0
Stock option exercises 165 22
Forward purchase agreement termination 0 12,730
Warrants exercised 50,589 2,243
Net cash provided by financing activities 60,754 48,268
Net increase in cash, cash equivalents and restricted cash 52,724 21,037
Cash, cash equivalents and restricted cash at beginning of the period 4,560 25,826
Cash, cash equivalents and restricted cash at end of the period 57,284 46,863
Less: restricted cash 2,042 62
Cash and cash equivalents 55,242 46,801
Supplemental disclosure of cash flow information    
Cash paid for interest, net 212 464
Cash paid for taxes 0 9
Noncash financing activities:    
Transaction costs 0 (23,663)
SAFE Agreements 0 20,667
Conversion of Series A preferred stock (Note 7) 23,120 0
Preferred dividends $ (471) $ (328)